Deconstructing an “Invisible” Failure

Depth-of-anesthesia monitoring is a critical safety line in surgery. Clinical studies show that bispectral index (BIS) monitoring can reduce the incidence of intraoperative awareness from 0.1%–0.2% by approximately 80%, making it a widely recognized reference standard for anesthesia depth monitoring. Everything depends on one thing: a single forehead sensor that must deliver a stable, continuous EEG signal to the monitor. Once it starts to “flicker,” the risk is real.

Q1 What problem did the customer face?

A European medical device manufacturer (anesthesia monitoring) reported an intermittent failure in its EEG/BIS sensor: the monitor could display a valid value, but the value would disappear shortly after appearing — repeatedly cycling through “value → disappears → recovers → disappears again.”

In the anesthesia monitoring context, signal interruption is a high-risk event. Since the sensor was supplied by the customer’s existing supplier, the customer asked VMANX to step in with an independent technical perspective to identify the root cause — a classic case of “supplier-side issue, third-party diagnosis.”

Fig. 1: BIS monitor interface as reported by the customer — value appears then disappears

Q2 What was the core contradiction?

Self-check (IC decoding, initial impedance test) passed, yet the live monitoring value disappeared — this is the most critical contradiction of the entire case.

It indicates the sensor’s initial electrical state was qualified; the fault developed during dynamic use. Value loss typically triggers the monitor’s “lead-off protection” or “poor signal quality” algorithm, pointing to two main directions: dynamic impedance fluctuation, or severe DC offset drift.

Conclusion: The problem most likely lies in the insufficient dynamic stability of the electrode material system (AgCl layer and hydrogel), not in initial assembly defects.

Q3 Which two root-cause directions were suspected?

Based on the typical structure of a BIS sensor — silver/silver chloride (Ag/AgCl) sensing layer + hydrogel conductive layer + polyester substrate — the failure hypotheses focused on two areas:

Combined assessment: AgCl formulation/thickness defects and hydrogel moisture retention/interfacial adhesion issues are likely present simultaneously — fixing only the hydrogel without fixing the AgCl will not stop the value from disappearing.

Q4 What 4-step troubleshooting method did VMANX provide?

To let the customer verify the hypotheses on-site without specialized equipment, the VMANX engineering team designed a practical four-step path:

Fig. 2: VMANX clinical-grade EEG electrode — 6-channel disposable frontal electrode (ISO 13485 / ISO 10993 / RoHS / REACH)

Fig. 3: BIS EEG sensor geometry — the AgCl layer and hydrogel interface are the focus of investigation

Q5 What lessons does this case offer to industry suppliers?

Working backward from the failure mechanism to manufacturing control, VMANX distilled the improvements into three actionable supplier control principles:

1. AgCl layer control cannot rely on dry film thickness alone. Electrochemical polarization testing is required — simulate human micro-currents for several hours and monitor DC offset stability, rather than relying only on static impedance sampling.

2. Hydrogel must not only conduct — it must “anchor.” The gel needs excellent anchoring to the AgCl surface, plus sweat resistance and anti-drying performance; interfacial treatment (e.g., primer/plasma) is the key process for suppressing bubbles and delamination.

3. Packaging seal determines product lifetime. Once a sensor is opened and exposed to air, hydrogel moisture begins to evaporate; high-barrier aluminum foil pouches + desiccant + open-date shelf-life labeling are baseline requirements for medical consumables.

Industry data shows high-quality hydrogel electrodes achieve 3–5kΩ impedance on unprepared skin, while conventional electrodes typically range 10–20kΩ — the gap in the material system directly determines clinical signal stability.

Q6 What role did VMANX play in this case?

As a professional manufacturer of flexible sensors and HMI components (Product families: F1 Medical & Healthcare MED / F4 Industrial Systems IND), the VMANX engineering team converts its deep understanding of material systems, printing processes, and failure mechanisms into third-party failure analysis capability.

In this engagement, VMANX delivered a full diagnostic chain from an independent technical perspective — “core contradiction analysis → root-cause hypotheses → on-site troubleshooting → improvement recommendations” — turning a vague “our supplier’s product doesn’t work” into an actionable corrective-action checklist.

For medical device manufacturers, having an engineering partner that understands materials, processes, and failure mechanisms is like adding a “technical insurance policy” to your supply chain. That is the value of VMANX’s engineering service capability.

Need Failure Analysis / Technical Diagnostics Support?

VMANX Engineering Center provides material failure analysis, supplier issue diagnosis, and improvement recommendations